While President Trump's State of the Union address is not finalized, he may plan to unveil a promise to end HIV transmission in America by 2030; a federal judge dismissed a lawsuit brought by Maryland that claimed the Trump administration is failing to enforce the Affordable Care Act; new cystic fibrosis (CF) treatments targeting the genetic mutations that cause the disease help about 90% of patients, meaning that 10% are still waiting for a cutting-edge therapy.
While President Trump's State of the Union address is not finalized, officials told Politico that he plans to unveil a promise to end HIV transmission in America by 2030. The plan, which has been championed by health officials, including HHS Secretary Alex Azar and Robert Redfield, head of the CDC, would target US communities with the most HIV infections.
A federal judge dismissed a lawsuit brought by Maryland that claimed the Trump administration is failing to enforce the Affordable Care Act (ACA), The Washington Post reported. The Maryland suit argued that the administration’s enthusiasm for sabotaging the law was evident when the United States refused to defend its constitutionality in a Texas ACA case against HHS. Late last year, a federal judge in Texas ruled that the entire law is unconstitutional. The judge who dismissed the Maryland lawsuit said that the state could revive it if it brings more proof that the administration is failing to stand by the law.
New cystic fibrosis (CF) treatments targeting the genetic mutations that cause the disease help about 90% of patients, meaning that 10% are still waiting for a cutting-edge therapy, STAT News reported. The difference has meant a gap in treatment for the illness, which is caused by more than 1500 mutations in the CFTR gene.
New Research Challenges Assumptions About Hospital-Physician Integration, Medicare Patient Mix
April 22nd 2025On this episode of Managed Care Cast, Brady Post, PhD, lead author of a study published in the April 2025 issue of The American Journal of Managed Care®, challenges the claim that hospital-employed physicians serve a more complex patient mix.
Listen
Personalized Care Key as Tirzepatide Use Expands Rapidly
April 15th 2025Using commercial insurance claims data and the US launch of tirzepatide as their dividing point, John Ostrominski, MD, Harvard Medical School, and his team studied trends in the use of both glucose-lowering and weight-lowering medications, comparing outcomes between adults with and without type 2 diabetes.
Listen
Integrated CKD Care Model Cuts ED Visits by 30%, Boosts Specialized Treatment
April 21st 2025An analysis of an interdisciplinary care model for managing chronic kidney disease (CKD) shows hospital admissions dropped by 26% and emergency department (ED) visits decreased by 30% after clinic initiation.
Read More